TWD 38.75
(-1.77%)
Year | Net Income | Net Income Growth |
---|---|---|
2023 | 73.61 Million TWD | 48.24% |
2022 | 49.66 Million TWD | 127.23% |
2021 | 21.85 Million TWD | 25.47% |
2020 | 17.41 Million TWD | -68.92% |
2019 | 56.04 Million TWD | 0.0% |
Year | Net Income | Net Income Growth |
---|---|---|
2024 Q3 | 15.07 Million TWD | -51.42% |
2024 Q1 | 24.37 Million TWD | 15.86% |
2024 Q2 | 31.03 Million TWD | 27.32% |
2023 Q3 | 19.42 Million TWD | 65.38% |
2023 Q4 | 21.03 Million TWD | 8.31% |
2023 Q2 | 11.74 Million TWD | -45.17% |
2023 Q1 | 21.41 Million TWD | -1.26% |
2022 Q4 | 21.69 Million TWD | 0.0% |
2022 FY | 49.66 Million TWD | 127.23% |
2021 FY | 21.85 Million TWD | 25.47% |
2020 FY | 17.41 Million TWD | -68.92% |
2019 FY | 56.04 Million TWD | 0.0% |
Name | Net Income | Net Income Difference |
---|---|---|
BIONET Corp. | 78.39 Million TWD | 6.1% |
Genetics Generation Advancement Corp. | 28.56 Million TWD | -157.717% |
Welgene Biotech Co.,Ltd. | -2.64 Million TWD | 2880.098% |
Puriblood Medical Co., Ltd. | -51.59 Million TWD | 242.682% |
TFBS Bioscience Inc. | 4.9 Million TWD | -1399.633% |